3D Cell Culture Market

3D Cell Culture Market Size & Growth (2019 - 2024)

The global 3D cell culture market size is expected to reach USD 1.69 billion by 2024, growing at a CAGR of 14.8% during the forecast period. The need to integrate 3D cell culture systems into research for a better representation of the environment has led to the development of new materials and methods, boosting the Global 3D Cell Culture Market growth.

The 3D cell culture market is expected to grow proteome gene expression and develop new vaccines and biopharmaceuticals. For decades, the animal 3D cell culture market has been widely used in animal research activities and drug testing, but 3D cell cultures can replace animals for research and testing.

The 3D cell culture market is growing steadily because of numerous factors. Such as, using 3D cell culture models as alternative tools for in vivo testing, developing large-scale automated cell culture systems, and increasing demand for organ transplants. Two-dimensional monolayer cell culture is used for cell-based screening and is considered an effective means of discovering new drug candidates.

However, two-dimensional cell culture has limitations such as loss of tissue-specific structures, loss of mechanical and biochemical cues, loss of cell-cell and cell-matrix interactions, and predicts drug response in certain diseases has become a relatively poor model. The advantages of 3D cell culture and co-culture models are that they can evaluate the safety and efficacy of drugs in a more in vivo environment compared to traditional 2D cell culture, as well as eliminate species with the limited interpretation we can do. Preclinical results are determined by drug tests directly in the human system. 3D cell culture is better than 2D cell culture. This is because cells can grow in any direction in vitro, similar to the way cells grow in vivo. Recruitment benefits researchers and drug developers because 3D cell culture has advantages over other tools. Therefore, due to these factors, the 3D cell culture market is expected to overgrow during the forecast period.

3D cell culture is more suitable for modeling in vivo due to its similarity with the morphology of organs or cells. The appearance of tests, kits, and protocols optimized in 3D, as well as the maturity in the development of different test techniques, should accelerate the growth of the market. The stem cell and cancer segment represented the largest market share in 2017. The market is dominated by North America, followed by Europe and the Asia Pacific.

It is expected that the increasing adoption of tissue engineering and organ transplantation for chronic diseases will favor adoption in research during the prognosis period. In addition, the use of microchips for cultivation through the use of microfabricated tissue components should provide potential customers with the Global 3D cell culture market. While the laboratory computing market represents significant growth opportunities, its growth may be hampered by the lack of infrastructure for 3D cell culture research. The market is very competitive with the presence of several large and small players.

Manufacturing techniques have emerged to produce transparent and cheap scaffolding systems that are compatible with liquid processing tools. The rapid adoption of these systems for tissue engineering research, drug discovery and personalized medicine contributes to Global 3D cell culture market growth. Technology without scaffolding is expected to grow more rapidly in the coming years, with an estimated CAGR of around 15.7% between 2019 and 2024.

Applicants tend to develop technology in the United States and Asia. In 2016, an international collaboration between the United States, the United Kingdom and the Netherlands aimed at culturing 1,000 new cell lines for scientists to study. The project is also expected to use state-of-the-art technology to generate models that include 3D cultures, called organoids, and cells that have been reprogrammed to expand indefinitely within the culture. 

ICTDCCS 2018, the 20th International Conference on 3D Cell Culture Systems, was held in Boston, USA, April 23-24, 2018. With the introduction of technological advances in the operation and design of these systems for researchers and laboratories, cell culture systems have the largest share in this market. The development of automated liquid handling systems is foreseen to improve culture capacity and maintain high purity in a reproducible manner.

REPORT COVERAGE:

This research report on the Global 3D Cell Culture Market segmented and sub-segmented into the following categories and analyzed market size and forecast for each segment until 2024.

3D Cell Culture Market Analysis – By Product:

• Scaffold-based 3D Cell Cultures
  • Hydrogels/ECM Analogs
  • Solid Scaffolds
  • Micropatterned Surfaces
• Scaffold-free 3D Cell Cultures
  • Low Attachment Plates
  • Hanging Drop Plates
  • 3D Bioreactors
  • 3D Petri Dishes
• Microfluidics-based 3D Cell Cultures       
• Magnetic & Bioprinted 3D Cell Cultures

Based on the product, it is expected that the scaffolding 3D cell culture segment will have the highest market share in 2018 and the highest CAGR in the forecast period. The strong growth of this segment is attributed to the ability of scaffolding products to mimic in vivo conditions, which favors their adoption by end-users.

3D Cell Culture Market Analysis – By Application:

• Cancer & Stem Cell Research
• Drug Discovery & Toxicology Testing
• Tissue Engineering & Regenerative Medicine

On the basis of application, the stem cell and cancer segment represented the largest market share in 2017. The growth of this segment of applications is attributed to the growing incidence of cancer and important funding initiatives for cancer research by governmental and private organizations.

3D Cell Culture Market Analysis – By End User:

• Pharmaceutical & Biotechnology Companies
• Research Institutes
• Cosmetics Industry
• Other End Users

3D Cell Culture Market Analysis – By Region:

• North America – United States, Canada and the Rest of North America
• Europe - UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe
• APAC - India, China, Japan, South Korea,  Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC
• Latin America - Brazil, Argentina, Mexico, Chile and Rest of Latin America
• Middle East and Africa -  KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA

Geographically, the market is dominated by North America, followed by Europe, Asia-Pacific and the rest of the world. The predominance of the North American 3D Cell Culture Market is attributed to factors such as the increase in the incidence of cancer, the presence of well-established pharmaceutical and biotechnological industries and the availability of technologically advanced products.

List of key market participants leading the Global 3D Cell Culture Market profiled in this report are:

1. MIMETAS
2. Hamilton Company
3. CN Bio
4. Advanced BioMatrix
5. Merck KGaA
6. REPROCELL Incorporated
7. Thermo Fisher Scientific
8. 3D Biotek
9. Lonza AG
10. Corning Incorporated
11. TissUse
12. PromoCell
13. InSphero
14. Synthecon